MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Shear wave sonoelastography is effective in detecting myofascial trigger points and spasticity

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The aim was to evaluate effectiveness of shear wave sonoelastography is effective in detecting myofascial trigger points (MTrP) and spasticity. Background: Ultrasound (US) revolutionized…
  • MDS Virtual Congress 2020

    Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE

    A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)

    Objective: Identify baseline clinical characteristics and treatment-related factors that impact adherence to onabotulinumtoxinA (onabotA) treatment in post-stroke and multiple sclerosis (MS) patients from the Adult…
  • MDS Virtual Congress 2020

    Cost-Analysis of the Use of IncobotulinumtoxinA and AbobotulinumtoxinA for the Treatment of Post-Stroke Upper Limb Spasticity Based on Recommended Dosing for Muscles and Clinical Patterns

    M.E Gendron, D. Vézina (Burlington, ON, Canada)

    Objective: To carry out a cost-analysis based on the respective recommended dosing per muscle using IncobotulinumtoxinA (INCO) and AbobotulinumtoxinA (ABO) for the treatment of post-stroke…
  • MDS Virtual Congress 2020

    Perceptions of burden of spasticity and treatment satisfaction among post-stroke patients over the course of a botulinum neurotoxin A (BoNT-A) treatment cycle: An ethnographic study

    J. Jacinto, A. Lysandropoulos, A. Fulford-Smith (Estoril, Portugal)

    Objective: To design an ethnographic study following patients over a botulinum toxin type-A (BoNT-A) treatment cycle to inform individualized treatment. Background: The concept of individualized…
  • MDS Virtual Congress 2020

    MDSGene Systematic Review: Genotype-Phenotype Relations for Hereditary Spastic Paraplegia Genes SPAST, ATL1 & REEP1

    C. Kang, J. Huang, R. Rajalingam, A. Rasheed, J. Zhang, Z. Walls, M. Hamed, M. Breza, S. Schaake, J. Massa, R. Massa, A. Shetty, C. Sue, R. Schule, F. Cambi, O. Suchowersky, F. Vulinovic, S. Petkovic, C. Klein, K. Lohmann, C. Marras, K. Kumar (St Leonards, Australia)

    Objective: To provide a comprehensive systematic review of the genotype-phenotype association in the most common three autosomal dominant genes of hereditary spastic paraplegia (HSP): SPAST,…
  • MDS Virtual Congress 2020

    Neuronal Inclusion Formation and Axonal Degeneration in Mutant TFG Transgenic Mice

    T. Kawarai, A. Orlacchio, R. Kaji (Tokushima, Japan)

    Objective: To investigate the TFG pathology by analyzing transgenic mice expressing mutant TFG protein. Background: It has been demonstrated that missense variants in TFG gene…
  • MDS Virtual Congress 2020

    Heterozygous mutation in CCDC88C gene as a cause of early onset pure hereditary spastic paraplegia

    A. Mohamed, S. Emad, R. Adil, L. Elsayed, A. Ahmed, G. Stevanin (Khartoum, Sudan)

    Objective: The objective of this study was to identify the molecular diagnosis of a Sudanese lady presenting with pyramidal signs and symptoms using whole exome…
  • MDS Virtual Congress 2020

    Transcutaneous spinal cord current stimulation modulate Reactive Oxygen Species (ROS) in multiple sclerosis patients

    S. Mrakic-Sposta, R. Ferrucci, S. Floro, F. Ruggiero, M. Vergari, S. Versace, S. Santoni, A. Vezzoli, M. Massei, M. Deriz, S. Marceglia, S. Barbieri, A. Priori (Milan, Italy)

    Objective: To investigate the effect of Transcutaneous spinal cord current stimulation (tsDCS) on oxidative stress in patients with multiple sclerosis (MS). Background: MS is a…
  • MDS Virtual Congress 2020

    Evaluating patient out-of-pocket (OOP) expenses using real world utilization data of botulinum toxins

    L. Turner-Stokes, A. Lysandropoulos, S. Wietek, C. Divers (Harrow, United Kingdom)

    Objective: The objective of this study was to evaluate the impact of different brands of botulinum neurotoxin type A (BoNT-A) on OOP patient spending based…
  • MDS Virtual Congress 2020

    Treatment of Medication-Refectory Holmes Tremor by Simultaneous Thalamic Ventral Intermediate (VIM) Nucleus and Subthalamic Nucleus (STN) Deep Brain Stimulation-A Case Report

    M. Anjum, C. Kalhorn, Y. Torres-Yaghi, A. Carwin, F. Pagan (Washington, DC, USA)

    Objective: To report a case of medication refractory Holmes tremor in a patient with pontine stroke and multisystem atrophy-cerebellar type (MSA-C) successfully treated with bilateral,…
  • « Previous Page
  • 1
  • …
  • 1164
  • 1165
  • 1166
  • 1167
  • 1168
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley